PMID: 8104183

Loo TW, Clarke DM
Functional consequences of phenylalanine mutations in the predicted transmembrane domain of P-glycoprotein.
J Biol Chem. 1993 Sep 25;268(27):19965-72., 1993-09-25 [PubMed]
Sentences
No. Mutations Sentence Comment
37 ABCB1 p.Phe777Ala
X
ABCB1 p.Phe777Ala 8104183:37:278
status: NEW
view ABCB1 p.Phe777Ala details
ABCB1 p.Phe777Ala
X
ABCB1 p.Phe777Ala 8104183:37:279
status: NEW
view ABCB1 p.Phe777Ala details
We found that changes to three phenylalanineresidues altered the activityof P-glycoprotein. Mutationof either Phe335 or Phe-978to Ala resultedinmutantsthatconferred altereddrugresistance profilessuggesting thatthese two residues play critical roles in drug transport activity.A Phe-777 to Ala changeresultedin a mutantproteinthat was defective in processing, suggesting that this residue is important for the biosynthesisof the protein. Login to comment
119 ABCB1 p.Phe978Ala
X
ABCB1 p.Phe978Ala 8104183:119:93
status: NEW
view ABCB1 p.Phe978Ala details
ABCB1 p.Phe335Ala
X
ABCB1 p.Phe335Ala 8104183:119:82
status: NEW
view ABCB1 p.Phe335Ala details
Functional Consequencesof Other Changes to Phe-335 and Phe-978"Mutation of either Phe-335 or Phe-978 to alanine had aprofound effecton the ability of P-glycoprotein to confer resistance to various cytotoxic compounds. Login to comment
120 ABCB1 p.Phe335Ser
X
ABCB1 p.Phe335Ser 8104183:120:111
status: NEW
view ABCB1 p.Phe335Ser details
ABCB1 p.Phe978Ser
X
ABCB1 p.Phe978Ser 8104183:120:122
status: NEW
view ABCB1 p.Phe978Ser details
To test theeffects of other changes to these two residues, site-directed mutagenesis was used to change either Phe-335 or Phe-978 to serine (polar residue), leucine (small non-polar residue),or to tyrosine (aromatic residue withpolar side chain). Login to comment
126 ABCB1 p.Phe978Ser
X
ABCB1 p.Phe978Ser 8104183:126:24
status: NEW
view ABCB1 p.Phe978Ser details
ABCB1 p.Phe978Tyr
X
ABCB1 p.Phe978Tyr 8104183:126:24
status: NEW
view ABCB1 p.Phe978Tyr details
ABCB1 p.Phe978Leu
X
ABCB1 p.Phe978Leu 8104183:126:24
status: NEW
view ABCB1 p.Phe978Leu details
Mutants with changes of Phe-978 to Ser, Leu, or Tyr all retained the ability to confer resistance to vinblastine, since drug-resistantcolonies were obtained after transfection with the corresponding mutant cDNAs. Login to comment
127 ABCB1 p.Phe978Ser
X
ABCB1 p.Phe978Ser 8104183:127:115
status: NEW
view ABCB1 p.Phe978Ser details
No colchicine-resistant colonies, however, were observed after transfection of cells with cDNAs coding for mutants Phe-978 Ser or Leu. Login to comment
134 ABCB1 p.Phe335Ala
X
ABCB1 p.Phe335Ala 8104183:134:12
status: NEW
view ABCB1 p.Phe335Ala details
Mutation of Phe-335 to Ala orSer actually reversed the preferential resistance of P-glycoprotein to vinblastine relative to colchicine. Login to comment
135 ABCB1 p.Phe335Ala
X
ABCB1 p.Phe335Ala 8104183:135:93
status: NEW
view ABCB1 p.Phe335Ala details
ABCB1 p.Phe335Ser
X
ABCB1 p.Phe335Ser 8104183:135:93
status: NEW
view ABCB1 p.Phe335Ser details
A vinblastine/colchicine ratio of 4.1 was obtained for the wild-type enzyme, whereas mutants Phe335 to Ala or Ser hadvalues of 0.59and 0.44respectively. Login to comment
160 ABCB1 p.Phe335Ala
X
ABCB1 p.Phe335Ala 8104183:160:12
status: NEW
view ABCB1 p.Phe335Ala details
Vinblastine Phe335-->Ala Wild-type -->Leu -->Ser Phe978-->Ah -->Tyr -->Ser ">Leu -->Tyr Colchicine 1 Adriamycin Actinomycin D 0.5 1 1.5 0.5 1 1.5 0.5 1 1.5 0.5 1 1.5 Relative Resistance FIG. 5. Comparision of relative resistances of stable cell lines expressing mutants Phe-335or Phe-978 +Ala, Ser, Leu, or Tyr. Login to comment
162 ABCB1 p.Phe335Leu
X
ABCB1 p.Phe335Leu 8104183:162:0
status: NEW
view ABCB1 p.Phe335Leu details
ABCB1 p.Phe335Tyr
X
ABCB1 p.Phe335Tyr 8104183:162:0
status: NEW
view ABCB1 p.Phe335Tyr details
Phe335 to Leu or Tyr gave vinblastine/colchicine ratios of 1.1and 3.5, respectively. Login to comment
166 ABCB1 p.Phe978Leu
X
ABCB1 p.Phe978Leu 8104183:166:16
status: NEW
view ABCB1 p.Phe978Leu details
Substitution of Phe-978 with Leu had an intermediate effect; drug transport was impaired for all four drugs with the greatest reduction occurring in the presence of colchicine and adriamycin. Login to comment
179 ABCB1 p.Phe335Ala
X
ABCB1 p.Phe335Ala 8104183:179:4
status: NEW
view ABCB1 p.Phe335Ala details
100 F335A -80 60 40 20 0 ' 1I I I I 10 100 1000 Vinblastine(ug/ml) FIG.7. Login to comment
183 ABCB1 p.Phe978Ala
X
ABCB1 p.Phe978Ala 8104183:183:43
status: NEW
view ABCB1 p.Phe978Ala details
0,wild-type;0,mutant Phe-335+Ala;W, mutant Phe-978 to Ala. Login to comment
221 ABCB1 p.Pro223Ala
X
ABCB1 p.Pro223Ala 8104183:221:26
status: NEW
view ABCB1 p.Pro223Ala details
We found that mutation of Pro-223 to Ala altered the substrate specificity of the transporter. Mutationof Pro-866, which resides in an equivalent position in the COOH-terminal half of P-glycoprotein when the two halves are aligned, also altered the substrate specificity of the enzyme. Login to comment
243 ABCB1 p.Phe335Ala
X
ABCB1 p.Phe335Ala 8104183:243:337
status: NEW
view ABCB1 p.Phe335Ala details
ABCB1 p.Phe335Ser
X
ABCB1 p.Phe335Ser 8104183:243:337
status: NEW
view ABCB1 p.Phe335Ser details
It has been found that mutations of Pro-223 toAla, Pro-866 toAla (Loo and Clarke, 1993), Phe-978 toAla or Ser (this study), and Ser-941 to Phe (Groset al., 1991) yield proteins that have reduced ability to conferresistanceto colchicine butretainthecapacity to conferresistancetovinblastine.The oppositeeffect is observed for mutation of Phe-335 to Ala or Ser (this study) or Gly-185 to Val (Choi et al., 1988). Login to comment